|Project Title||FDA Sentinel System’s Coronavirus (COVID-19) Activities|
FDA’s Sentinel System is engaged in numerous activities to protect and promote public health during the COVID-19 pandemic, ranging from monitoring the use of drugs, describing the course of illness among hospitalized patients, and evaluating the treatment impact of therapies actively being used under real-world conditions. Descriptions of efforts led by the Center for Drug Evaluation and Research are detailed in the link below.
Tuesday, April 21, 2020
- Vaccines, Blood & Biologics
- Devices and Radiologic Health